Compare Inovio Pharmaceuticals Inc (INO) vs Old Dominion Freight Line Inc (ODFL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Old Dominion Freight Line Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $1.09 (market cap $89.27M), while Old Dominion Freight Line Inc trades at $233.45 (market cap $48.20B). The key difference: Old Dominion Freight Line Inc is far larger — about 539.9× Inovio Pharmaceuticals Inc's market cap, and Old Dominion Freight Line Inc pays a 0.5% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | ODFL | |
|---|---|---|
Market Cap | $89.27M | $48.20B |
Sector | Health | Industrials |
52-Week High | $2.87 | $248.73 |
52-Week Low | $1.05 | $126.29 |
Enterprise Value | $60.28M | $47.95B |
Dividend Yield | — | 0.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INO trades at $1.07, down 4.46% today, reflecting persistent bearish technical signals. The company shows minimal revenue of $65.34K (2025) with a net loss of $84.95M, resulting in a negative net margin of 130,000%. Despite beating recent EPS estimates, cash flow remains negative. Key near-term catalyst is the FDA's PDUFA decision on INO-3107 by October 30, 2026.
Outlook hinges on regulatory success for INO-3107; approval could drive significant upside, but failure poses substantial risk. High cash burn and lack of profitability underscore speculative nature. Analyst consensus is cautiously optimistic with 53% buy ratings, yet financial health remains precarious without near-term revenue growth.
Old Dominion Freight Line (ODFL) trades at $231.79, down 0.88% on the day, with a bullish technical signal supported by moving averages. The company maintains strong profitability with an 18.46% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights improved LTL metrics and a quarterly dividend of $0.29 per share, though valuation remains elevated with a P/E of 48.82.
ODFL's outlook is supported by operational excellence and a debt-light balance sheet, but high valuation and competitive pressures from players like Amazon pose risks. Analyst consensus is mixed with a $233.67 price target, suggesting limited upside from current levels amid economic uncertainties in the freight sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Old Dominion Freight Line Inc
Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →
